Agomab Therapeutics NV - AGMB

Sector: Healthcare · Industry: Biotechnology
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026
Value (USD)
Total reported value ($000)
$245.3M
QoQ value delta ($000)
Shares
Total shares
23,354,227
QoQ shares delta
Total shares held by funds (by quarter)

Market chart (AGMB)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Manager Value ($000) Shares % of 13F
EQT Fund Management S.a r.l. 53,939 5,141,992 5.28%
Sanofi 29,194 2,783,096 8.69%
Cormorant Asset Management, LP 25,861 2,465,348 1.3%
TCG Crossover Management, LLC 21,538 2,053,233 0.62%
FEDERATED HERMES, INC. 16,972 1,618,000 0.03%
Casdin Capital, LLC 16,259 1,550,000 1.23%
Andera Partners 16,140 1,538,702 9.12%
FMR LLC 15,301 1,458,677 0.0%
Nantahala Capital Management, LLC 12,852 1,200,000 0.47%
Aberdeen Group plc 7,423 707,656 0.01%
PERCEPTIVE ADVISORS LLC 6,294 600,000 0.12%
Samsara BioCapital, LLC 6,294 600,000 0.61%
Siren, L.L.C. 4,314 411,250 0.12%
LMR Partners LLP 3,147 300,000 0.01%
SEVEN GRAND MANAGERS, LLC 2,098 200,000 0.14%
Redmile Group, LLC 1,639 156,250 0.11%
MILLENNIUM MANAGEMENT LLC 998 95,233 0.0%
PFIZER INC 813 75,000 0.34%
Alyeska Investment Group, L.P. 786 75,000 0.0%
Laurion Capital Management LP 524 50,000 0.02%
Bellevue Group AG 524 50,000 0.01%
SECTORAL ASSET MANAGEMENT INC 477 43,500 0.4%
GOLDMAN SACHS GROUP INC 374 35,739 0.0%
CITADEL ADVISORS LLC 367 35,000 0.0%
Burkehill Global Management, LP 367 35,000 0.02%